Fox Business - The Power to Prosper
Search Site

Novartis

Lessons Learned from Business Failures

Hiding inside failures are the seeds of success. You just have to find them. Here are tips.

Read More

  1. Firms Race for Slice of $7.5B Asthma Market

    Rival firms are racing to develop injectable biotech asthma drugs for patients with severe disease who don't respond well to traditional inhalers, in pursuit of a ne...

  2. Hang Out on the Sidelines

    Boy, I go away for a week, the market rallies.  I return, it drops.   I know, it's silly, but this is sometimes exactly how traders think.Yet, while I don't think I'...

  3. European Stocks Slide For Third Day

    European stock markets opened with broad-based losses on Friday, as ongoing tensions in Ukraine and worries about slowing economic growth in China hampered the inves...

  4. European Stocks Eye Weekly Loss Ahead of U.S. Jobs Data

    European stock markets headed lower on Friday, with the benchmark index heading for its first weekly loss since January, as investors remained cautious ahead of nonf...

  5. European ETFs Flying Under The Radar

    The S&P 500 hit a new all-time high on Monday, and the NASDAQ is trading at the best level in 13 years.Both indices are in the midst of a strong bull market -- but t...

  6. Tokyo prosecutors raid Novartis Japan offices in probe

    Prosecutors in Tokyo raided offices of Swiss drugmaker Novartis on Wednesday as part of an investigation into alleged use of manipulated data to promote its best-sel...

  7. Nestle Hints At More Deals After Healthcare Venutres

    Swiss food giant Nestle's deeper dive into healthcare by taking over the dermatology joint venture it had with L'Oreal suggests further deals in the space are likely...

  8. Pill helps you protect your digital passwords

    Safety vitamin emits signal to unlock gadgets

  9. Biotechs Still Hold Promise in 2014 and Beyond

    As a group, biotech companies were among the best performers in what was a stellar year for U.S. stocks: The group was up 66%, outpacing the broader market by a stag...

  10. Novartis CEO: Universal health coverage in U.S. is a good objective

    Novartis CEO Joe Jimenez on being one of the Chairs of the World Economic Forum, the drugs in the company’s pipeline and ObamaCare.

  11. Returns May Suffer in Crowded Cancer Drug Field

    Pharmaceutical companies including Switzerland's Novartis and Roche are among those developing a treatment for a specific type of lung cancer, a field that is now so...

  12. Stoxx Europe 600 Eyes Best Week Since April

    European stock indexes headed for the strongest weekly gain since April on Friday, as the U.S. Federal Reserve's tapering decision spurred optimism about the U.S. ec...

  1. GSK Faces Criminal Bribery Investigation In Poland

    GlaxoSmithKline is facing a criminal investigation in Poland for allegedly bribing doctors to promote its lung drug Seretide, adding to problems for a company alread...

  2. Novartis Files Patent Suit Against Biocon

    Novartis has taken India's Biocon to court for infringing the patent on its diabetes drug Galvus, the Swiss drugmaker said in a statement on Thursday.The Basel-based...

  3. European Stocks Climb Ahead Of Inflation Data

    European stock markets kicked off the week on a strong footing on Monday, with investors awaiting the first reading on inflation in the euro zone in March. Analysts ...

  4. Baxter to Split Itself into Two Companies

    Baxter International (NYSE:BAX) unveiled plans on Thursday to split itself into two separate companies, creating an independent biopharmaceuticals firm.A second comp...

  5. Sanofi Faces Verdict on Big Dengue Vaccine Bet

    Sanofi expects final clinical results for its vaccine against dengue by late September, the French drugmaker's project leader has told Reuters, and has already gambl...

  6. European Stocks Rebound Ahead Of German Ifo, U.S. Data

    European stock markets rebounded from sharp losses at the open on Tuesday, with banks and drug makers in the lead, as investors waited for German business-confidence...

  7. Novartis CEO Reshapes Firm For 'Brutal' New World

    Novartis Chief Executive Joe Jimenez is taking a hard look at the drugmaker's smaller businesses as he reshapes the company for what he expects to be a "brutal" new ...

‹ Prev12345Next ›
Freebase CC-BY
Source: Novartis on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL